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Objective: The optimal technique for aortic arch reconstruction through median
sternotomy is still under debate. We have introduced the technique of pulmonary
autograft patch aortoplasty as a reliable alternative.
Methods: The outcomes of 51 infants who underwent neonatal repair of interrupted
aortic arch (n = 28) or coarctation associated with ventricular septal defect (n = 23)
since 1992 were analyzed. The patients were reviewed in three groups according to
the aortic arch reconstruction technique: group I underwent direct anastomosis (n =
23), group II underwent homograft or pericardial patch aortoplasty (n = 8), and
group III underwent pulmonary autograft patch aortoplasty (n = 20). The pul-
monary autograft patch consisted in the anterior wall of the main pulmonary artery,
between the supracommissural level and the divided ductus arteriosus. The created
defect was replaced with fresh autologous pericardium.
Results: All patients except 1 were discharged without significant residual gradient
at the level of the aortic arch. At a median delay of 7 months (range 2-51 months),
11 patients (22%) had recurrence of arch obstruction and underwent balloon angio-
plasty (n = 8) or surgical correction (n = 3). One patient who had undergone direct
anastomosis required reoperation for bronchial compression. At a median follow-up
of 29 months, the actuarial freedoms from recurrent arch obstruction were 81% for
direct anastomosis, 28% for homograft or pericardial patch aortoplasty, and 100%
for pulmonary autograft aortoplasty (P = .03 for group III vs group I and P < .0001
for group III vs group II).
Conclusions: The aortic arch repair associated with pulmonary autograft patch aug-
mentation resulted in superior midterm outcomes and therefore constitutes a reli-
able alternative to the direct anastomosis technique. It allowed complete relief of
anatomic afterload and diminished the anastomotic tension, thus reducing the risk
of restenosis and tracheobronchial compression. We observed a significantly higher
rate of recurrence after patch aortoplasty with other materials.
The surgical experience of the last decade has allowed us to evaluatethe advantages of single-stage biventricular repair of aortic archobstruction and associated intracardiac defects during the neonatalperiod.1-4 However, debate continues regarding the method of aorticarch reconstruction itself. Resection and primary anastomosis con-stitutes the most commonly used technique, with a rate of recurrence
varying between 5% and 25% according to reported series.5-8 To avoid recurrence,
patch augmentation of the aortic arch (and when necessary the ascending aorta) has
been proposed as an alternative.4,9,10 Homograft, xenograft, and synthetic materials
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have been used. The patch augmentation technique with
biologic materials has also resulted in a considerable rate of
recurrence. However, the use of synthetic patches in
neonates presents technical difficulties, and the late devel-
opment of aortic aneurysm is common.11
Pulmonary autograft patch aortoplasty is an easy and
reproducible technique that permits aortic arch augmenta-
tion by means of a viable tissue patch. It has been used since
1997 in combination with resection and end-to-end anasto-
mosis for the treatment of interrupted aortic arch (IAA) as
well as coarctation. This article reports a retrospective com-
parative analysis of our recent experience with different
techniques, with particular attention to the outcome of the
reconstructed aortic arch.
Patients and Methods
Patients
The study cohort consisted of 54 consecutive patients operated on
between January 1992 and December 2000. Six of the patients
were operated on by one of the authors (E.B.) at a second institu-
tion. All patients except 1 underwent single-stage biventricular
repair for aortic arch obstruction and associated intracardiac
defects. Only patients operated on during the neonatal period (<30
days after birth, n = 49) and patients with ductus-dependent lower
body perfusion beyond the first month of life (n = 4) were included
in this study. Patients with associated transposition of the great
arteries or truncus arteriosus and those for whom a univentricular
palliation was expected were not included. The median age at
operation was 12 days (range 3-81 days), and the median weight
was 3.1 kg (range 2-4 kg). Prostaglandin E1 administration was
necessary for 29 patients. Six patients were critically ill, requiring
ventilatory support, and 7 patients received inotropic support. Di
George syndrome was diagnosed in 14 cases. All patients were
evaluated preoperatively by echocardiography. Cardiac catheteri-
zation was performed in 6 cases. The anatomic features of the aor-
tic arch and the site of interruption were determined according to
the classification of Celoria and Patton.12 There were 30 cases of
IAA associated with ventricular septal defect (VSD) and 24 cases
of coarctation associated with VSD (double-outlet right ventricle
in 1 case; Table 1). The coarctation was associated with aortic arch
hypoplasia in most cases (n = 21, 88%), with the mean diameter of
the aortic arch being 2.9 ± 0.6 mm. The associated lesions were 18
cases of subaortic stenosis,2 3 cases of multiple VSDs, 1 case of
aortopulmonary window, 1 case of left pulmonary artery arising
from the aorta, and 1 case of left atrial isomerism. VSDs were peri-
membranous (n = 41), muscular (n = 6), or infundibular (n = 4).
Surgery
The technical approaches for arch reconstruction started from the
same principles, the systematic resection of all ductal tissue and
extensive mobilization of the descending aorta. A direct anastomo-
sis between the two aortic segments was performed in 23 cases
(group I). In the presence of IAA the descending aorta was anasto-
mosed end-to-side to the lateral aspect of the distal part of the
ascending aorta. In cases of coarctation the previously described
Figure 1. Drawing representing aortic repair technique by means of pulmonary autograft patch augmentation.
TABLE 1. Patient groups
Group I Group II Group III Total
(n = 23) (n = 8) (n = 23) (n = 54)
IAA and VSD 15 3 12 30
Type A 3 0 0 3
Type B 11 2 11 24
Type C 1 1 1 3
Coarctation and VSD 8 5 11 24
Group I underwent repair by direct anastomosis, group II with a pul-
monary homograft patch (n = 4) or a xenopericardial patch (n = 4), and
group III with a pulmonary autograft patch.
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extended end-to-end repair was performed.13 In the remaining 31
cases, after incision of the lateral aspect of the ascending aorta and
the concavity of the aortic arch proximal to the resected coarctation,
an end-to-side anastomosis (in cases of IAA) or extended end-to-
end anastomosis (in cases of coarctation) was done in all cases by
leaving around a third of the most proximal anastomosis open
(Figure 1, A). The medial aspect of the descending aorta was incised
15 to 20 mm distal to this anastomosis. The defect was then aug-
mented with a pulmonary homograft patch (n = 4) or a xenopericar-
dial patch (n = 4) in 8 cases (group II). In the study technique, the
defect was augmented with a pulmonary autograft patch (group III,
n = 23; Figure 1, B). In 3 neonates with coarctation and severe arch
hypoplasia (<3 mm), after ligation of the isthmus the descending
aorta was anastomosed end-to-side to the ascending aorta–proximal
arch junction, and that join was augmented with the pulmonary
autograft patch.14 The size and also the elasticity of the pulmonary
autograft patch permitted adequate augmentation of the aortic arch
in all cases. In cases of ductus-dependent lower body perfusion, the
main pulmonary artery is by definition dilated. The pulmonary auto-
graft patch consisted of the anterior wall of the main pulmonary
artery, between the supracommissural level and the ligated ductus
arteriosus. Harvesting of the autograft patch started at the proxi-
mally situated pulmonary arterial cannulation site. Particular atten-
tion was paid to staying at a distance from both pulmonary artery
branches’ ostia. The created defect in the main pulmonary artery
was replaced with a xenopericardial patch in 2 cases at the begin-
ning of the experience and by fresh autologous pericardium in the
last 20 cases (Figure 1, B). The pulmonary artery was directly closed
in 1 case because of its large size.
The aortic arch repair was performed with the patient in deep
hypothermic circulatory arrest in 32 cases; the remaining 22
patients (38%, 70% confidence interval [CI] 31%-46%) were oper-
ated on with continuous cardiopulmonary bypass and hypothermia
but without total circulatory arrest.15 During arch reconstruction
the extremity of a malleable arterial cannula (model 77008;
Medtronic DLP, Grand Rapids, Mich) was introduced into the
innominate artery; the innominate artery was snared, and the flow
was diminished by around 50% to maintain a mean arterial pres-
sure of 30 to 40 mm Hg. The median aortic crossclamp time was
63 minutes (range 27-182 minutes), the median cardiopulmonary
bypass time was 130 minutes (range 90-317 minutes), and for the
32 patients for whom a period of total circulatory arrest was done
the median circulatory arrest time was 31 minutes (range 18-95
minutes). The intracardiac repair was performed by previously
described techniques for each specific malformation. The left ven-
tricular outflow tract was examined. Eighteen patients had evidence
of subaortic stenosis. Subaortic myotomy or myectomy was per-
formed only in 3 cases. Among the 2 other cases with a virtually
occluded subaortic region, biventricular repair was achieved by a
Ross-Konno procedure in 1 case; the other patient underwent a
Damus-Kaye-Stansel and Rastelli operation. The subaortic narrow-
ing was ignored in the remaining 13 cases. The VSD was closed
through the right ventricle in 37 cases, the right atrium in 10 cases,
and the pulmonary artery in 6 cases. Polyester (Dacron) or pericar-
dial (in the case of infundibular VSD and to preserve the pulmonary
valve function) patches were used. The patient with double-outlet
right ventricle and restrictive subaortic VSD associated with coarc-
tation and hypoplastic aortic arch and left atrial isomerism under-
went VSD enlargement followed by an intracardiac baffle repair. A
patient with type A IAA who had the biventricular repair aban-
doned intraoperatively because of Swiss cheese–type VSDs and
instead underwent pulmonary artery banding was also included in
the study group. A patient with an associated aortic valve stenosis
required a concomitant commissurotomy. The associated aortopul-
monary window was closed by means of a pericardial patch. A left
pulmonary artery arising from the aorta was reimplanted in 1 case.
Delayed sternal closure was necessary in 21 cases.
During the study period the concomitant VSD and coarctation
repairs were performed in 5 other infants beyond the neonatal
period (3 of them were 2 months old, 1 was 3 months old, and 1
was 4 months old) by pulmonary autograft patch augmentation.
Data Analysis
Perioperative data were collected by retrospective review of
patient records. Medical records, echocardiographic and cardiac
catheterization data, and operative notes were all reviewed. Early
survivors were considered to be patients who were discharged
alive from the hospital and survived at least 30 days from the time
of repair. Recurrent arch obstruction was defined as a resting sys-
tolic pressure gradient greater than 20 mm Hg during catheteriza-
tion. Follow-up was carried out by means of physician contact
with each patient and was based on clinical and echocardiographic
data. Time-related events were examined by actuarial methods.
Comparisons between time-related events were performed with
the log-rank test. Ratios were expressed with 70% CIs. To com-
pare the three groups, the t test was used for continuous variables
and the χ2 test was used for dichotomous variables.
Results
Early Results
There were 3 early deaths among the 54 patients (6%, 70% CI
2%-11%). One patient with IAA died of RSV pneumonia.
The second patient with coarctation and VSD died after an
early reoperation for supravalvular aortic stenosis. The third
patient with coarctation and VSD had a perioperative myocar-
dial infarction develop; he underwent urgent heart transplan-
tation, and multiple organ failure was the cause of death.
One patient with IAA and right aortic arch could not be
weaned from mechanical ventilation because of right
bronchial compression. He underwent a reoperation in
which an aortopexy was performed through a right thoraco-
tomy. At discharge all the patients were evaluated by
echocardiography. Only 1 patient showed significant gradi-
ent at the level of the reconstructed aortic arch, and the
mean gradient was 8 ± 12 mm Hg.
Late Results
The 51 survivors were analyzed in 3 groups according to the
arch repair technique. A median follow-up of 29 months
(range 3 months–9 years, median 41 months for group I,
median 18 months for group II, and median 9 months for
group III) was achieved for 100% of survivors as of
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February, 1, 2001. There were 2 noncardiac late deaths (4%,
70% CI 1%-9%): 1 patient with IAA died 18 months after
the operation of persistent pulmonary hypertension and
bronchitis related to inhalation pneumonia, and 1 patient
with IAA was operated on because of complex urinary mal-
formations and died after that operation.
Reoperations
Eleven patients underwent 18 reoperations. There were 11
cases of recurrent aortic arch obstruction managed by
surgery (n = 3) or balloon angioplasty (n = 8) at a median
delay of 7 months (range 2-51 months, 22%, 70% CI 15%-
29%; Table 2). For 2 of the patients for whom the recurrence
relief was performed surgically, the principal cause for reop-
eration was residual VSD in 1 case and subaortic stenosis in
the other. The technique of pulmonary autograft aortoplasty
was associated with no recurrent coarctation (P = .03 for
group III vs group I and P < .0001 for group III vs group II).
At a median follow-up of 29 months (range 3 months–9
years), actuarial freedoms from recurrent arch obstruction
were 81% (70% CI 66%-88%) in group I, 28% (70% CI 9%-
50%) in group II, and 100% in group III (Figure 2). The inci-
dences of recoarctation were similar after coarctation and
IAA repairs: 26% (70% CI 16%-39%) after coarctation
repair versus 21% (70% CI 13%-38%) after IAA repair. One
patient had pulmonary stenosis develop as a result of
xenopericardial patch retraction and underwent reoperation
at a delay of 8 months. Five patients underwent 8 reopera-
tions because of left ventricular outflow tract obstruction,
including 4 subaortic stenosis resections, 1 modified Konno
procedure, and 3 Ross-Konno procedures.
Patient Status
At last visit all survivors were free of symptoms.
Echocardiography showed a mean gradient of 10 ± 10 mm
Hg at the level of the aortic arch. A residual significant pres-
sure gradient was observed in 2 patients who had already
undergone balloon angioplasty for recurrence after direct
anastomosis. The patient for whom the pulmonary artery
was reconstructed without patch interposition had a pul-
monary stenosis develop, with a maximal gradient of 80
mm Hg according to echocardiography. All remaining
patients for whom the pulmonary artery reconstruction was
performed with a fresh pericardial patch showed normal
pulmonary valve function, without any pressure gradient or
regurgitation. One other patient with hypoplastic aortic
valve anulus will eventually require a reoperation because
of a transvalvular gradient of 75 mm Hg. The 5 additional
patients who underwent pulmonary autograft patch aorto-
Figure 2. Actuarial freedom from recurrent arch obstruction for groups I (diamonds), II (squares), and III (triangles).
TABLE 2. Reoperations
Group I Group II Group III Total
(n = 23) (n = 8) (n = 23) (n = 54)
Total patients 23 8 20 51
Recurrent arch obstruction* 5 6 0 11
Surgery 1 2 0 3
Balloon angioplasty 4 4 0 8
Left ventricular outflow tract 2 2 1 5
obstruction
Group I underwent repair by direct anastomosis, group II with a pul-
monary homograft patch (n = 4) or a xenopericardial patch (n = 4), and
group III with a pulmonary autograft patch.
*P = .03 for group III versus group I and P < .0001 for group III versus group II.
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plasty beyond the neonatal period were also free of symp-
toms without any significant gradient.
Discussion
The first single-stage repair of type A IAA was reported by
Barratt-Boyes and associates16 in 1970. Early diagnosis and
preoperative resuscitation through the use of prostaglandins
have reduced postnatal mortality and increased the number
of candidates for surgical treatment. Finally, improvements
in neonatal cardiopulmonary bypass, myocardial protec-
tion, and surgical technique permitted the routine single-
stage management of aortic arch obstruction associated
with intracardiac defects. During the last decade several
groups have reported low mortalities and satisfactory clini-
cal outcomes.1-5,9 At present many groups advocate the
advantages of single-stage relative to staged management.
Nevertheless, the staged approach remains indicated for
conditions such as the presence of severe multiple VSDs,
neurologic disorders, and multiple organ failure.
The aortic arch repair technique has also evolved with
time. The most severe forms of arch hypoplasia are now
currently treated through sternotomy. Debate persists, how-
ever, and although direct anastomosis appears to be pre-
ferred by most authors, no technique has proved its
superiority. The extensive mobilization of the descending
aorta allows the performance of a direct anastomosis in
almost all cases, but the tension on the suture line and the
presence of residual ductal tissue can result in a consider-
able rate of recurrence (5% to 25% in recent reports).5-8 The
mechanism appears to be multifactorial and related to the
stretching, resulting in diminution of effective vascular
diameter and loss of the aortic wall’s elasticity and potential
for growth. One should also consider that previously
reported series included patients beyond the neonatal period
in most instances; these cases probably presented less sur-
gical challenge and carried the potential for superior out-
come. In this report only neonates and 4 additional infants
with ductus-dependent descending aortic perfusion were
studied. The aim was to form a homogeneous cohort of
patients with complex disease. The observed rate of recur-
rence after direct anastomosis was similar to those in other
experiences (19%). No predictive factor for recurrence after
this technique was revealed.
Bronchial compression is a rare but consistent complica-
tion observed after large conduit interposition and also
direct anastomosis. It may result from excessive tension
between the two aortic ends.1,17 Also, the connection of the
descending aorta proximally in the ascending aorta to
diminish the tension and to perform a larger anastomosis
can cause bronchial compression. In our series 1 patient
who underwent repair of type B IAA with right descending
aorta by means of direct anastomosis had right bronchial
compression develop. Diagnosis was made by fibroscopy.
Both tension and the relatively proximal location of the
anastomosis were responsible. Weaning from mechanical
ventilation was possible after an early reoperation in which
an aortopexy through right thoracotomy was performed.
One other inconvenience of the direct anastomosis tech-
nique is its limitation in case of the need for ascending aorta
augmentation, which is not uncommon in the studied sub-
group of patients.
The enlargement of the aortic arch by means of a patch
constitutes a valuable alternative to primary anastomosis.
This technique was proposed with the aim of complete
relief of anatomic afterload and a tension-free anastomosis.
It was frequently combined with resection and end-to-end
anastomosis. Most published series have suggested the use
of homograft patches.2,4,5 Several reports have presented
low rates of recurrence.4,10 In this series 8 patients had end-
to-end repair associated with homograft (n = 4) or xenoperi-
cardial (n = 4) patch augmentation: 6 required reoperation
for recurrence, 3 after homograft patches and 3 after
xenopericardial patches. Recurrence may be due to rheo-
logic as well as immunologic factors. Although synthetic
(polytetrafluoroethylene or polyester) patches have also
been presented as an ideal solution, the technical difficulties
of inserting a synthetic patch in a neonate and the constant
risk of late aneurysm formation have been enough for that
to be abandoned as an alternative.11
Balloon angioplasty for aortic recoarctation after surgi-
cal repair has become the method of choice during the past
decade. Long-term data are still minimal, however, and the
procedure is not free of complications.18,19 In addition, in
the particular subset of patients studied here the recurrence
was often extremely proximally situated, making the angio-
plasty procedure challenging and an eventual stenting
impossible. Thus balloon angioplasty for recurrence after
neonatal surgical treatment of IAA or severe coarctation
through sternotomy might have a relatively poor outcome:
among the 8 patients who required balloon angioplasty for
recurrence, 2 have already undergone a second angioplasty
procedure and 2 had significant residual gradients.
There are several limitations to this study. First, it is a
retrospective analysis. In addition, there is a potential for
patient selection bias. All patients who underwent pul-
monary autograft patch repair were operated on during the
last 3 years. Standardized techniques were used in all cases,
however, and the selection of a highly homogeneous study
cohort was intended to limit the potential for bias.
One of the major controversies regarding the use of the
pulmonary autograft patch is the eventual deterioration of
the pulmonary valve. The patient population presented here
had hypoplastic left heart aorta complex in a majority of
cases and there were 18 patients with a subaortic narrowing
to less than a Z score of –6.2 Three patients had already
undergone a Ross or Ross-Konno procedure, and there will
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certainly be at varying delays other candidates for such a
procedure.2,6 Because we used fresh autologous peri-
cardium as substitute, we did not observe pulmonary valve
dysfunction on echocardiography. It is true that in 1 case of
neonatal type B IAA repair by means of pulmonary auto-
graft patch augmentation of the ascending aorta and the
anastomosis, the subaortic narrowing (3.5 mm) was
ignored. At a delay of 6 months this patient required relief
of a subaortic stenosis by myectomy. He had a recurrence of
the subaortic obstruction, and a Ross-Konno procedure was
performed at 14 months of age (Figure 3). The pulmonary
valve and its postoperative function in the aortic position
were normal.
In conclusion, aortic arch repair associated with pul-
monary autograft patch augmentation results in superior
midterm outcomes and constitutes a reliable alternative to
the direct anastomosis technique. It permits complete relief
of anatomic afterload and diminishes the anastomotic ten-
sion, thus reducing the risk of restenosis and tracheo-
bronchial compression. We observed a significantly higher
rate of recurrence after patch aortoplasty with homograft
and pericardial patch augmentation.20
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Discussion
Dr J. William Gaynor (Philadelphia, Pa). I congratulate
Roussin and colleagues for their study describing an innovative
technique for arch reconstructions in infants with aortic arch
obstruction and either coarctation or interruption of the aortic arch.
Particularly for patients with coarctation and VSD, there is an
ongoing debate concerning the optimal management strategy. A
multi-institutional study sponsored by the Congenital Heart
Surgeons Society suggested that survival was greatest with a staged
approach, with initial coarctation repair and pulmonary artery
banding followed by delayed VSD closure. However, there are
potential significant advantages to correction of all hemodynamic
abnormalities at the initial operation with no obligate need for reop-
eration. Advocates of the staged approach have suggested that such
a strategy is associated with a lower mortality, a lower incidence of
recurrent arch obstruction, and avoidance of the need for deep
hypothermic circulatory arrest during the arch reconstruction.
This study and recent reports from other institutions, including
our own, have demonstrated that a single-stage strategy can be
accomplished with low mortality and an acceptable incidence of
recurrent arch obstruction. With the use of isolated cerebral perfu-
sion, such as Roussin and colleagues describe, there is no need for
circulatory arrest during the arch reconstruction.
Unfortunately, there are few long-term follow-up data for either
of these strategies, especially in terms of hypertension, ventricular
dysfunction, and neurodevelopmental outcome. In addition, as
Roussin and colleagues note and other studies have confirmed,
subaortic narrowing is common. Even after successful repair, these
patients are at risk for development of additional levels of left ven-
tricular outflow tract obstruction, particularly subaortic stenosis.
We have found, as did Roussin and colleague, a significant inci-
dence of reintervention for other levels of left ventricular outflow
tract obstruction, often within a few years of the original operation.
Many children eventually require a Ross-Konno procedure for
complex left ventricular outflow tract obstruction. Thus, although
the approach described here is attractive, potential damage to the
pulmonary valve is a major concern with this technique.
I have several questions. First, the use of isolated cerebral per-
fusion during arch reconstruction is an appealing and increasingly
popular technique; however, there are few data concerning long-
term neurodevelopmental outcomes with this technique. Have you
formally investigated the neurodevelopmental outcomes among
your patients?
Second, in the article you noted that most VSDs were closed
through a right ventriculotomy. These VSDs are usually accessible
with an approach across the tricuspid valve, so why was a ven-
triculotomy used?
Third, although you noted that 1 patient underwent a success-
ful Ross procedure, you did not provide data concerning the inci-
dence of pulmonary artery distortion and pulmonary insufficiency
among these patients, which is obviously going to be important in
the long term. Have you formally evaluated the function of the pul-
monary valve in all of your patients?
Finally, given the significant incidence of subaortic narrowing
and the need for reintervention for subaortic stenosis, is there a
subset of these patients for whom a neonatal Ross-Konno proce-
dure should be performed as part of the initial repair?
Dr Belli. Concerning the isolated perfusion of the brachio-
cephalic trunk, Dr Gaynor, unfortunately at present we do not have
any data about the neurologic development of those children. This
aspect can be evaluated by a randomized comparative series. The
isolated cerebral perfusion was performed under conditions that
were not far from total circulatory arrest technique, with the tem-
perature being under 25°C, usually 20°C. We tried to have the
highest flow, which was almost always between 30% and 50% of
the theoretic perfusion flow, and arterial blood pressure monitor-
ing in the right radial artery permitted us to maintain a pressure
between, again, 30 and 50 mm Hg. The perioperative serum lac-
tate levels appeared significantly inferior with selective perfusion
of the brachiocephalic trunk.
With respect to the right ventriculotomy approach, this is our
preferred approach for those anomalies at Marie Lannelongue
Institute: we often perform the VSD closure in the neonatal period
through right ventriculotomy, particularly in the presence of
conoventricular malalignment VSDs. The right atriotomy
approach can require more traction, can take more time, and can
be challenging with the bicaval cannulation and continuous perfu-
sion technique that we use. It can also result in tricuspid valve dis-
tortion. In addition, we did not observe any negative effects of
those limited right ventriculotomies on early and late outcomes;
this information was already reported.
Concerning the pulmonary valve function, I did not mention
that after echocardiographic evaluation the pulmonary valve func-
tion was found normal in all patients who received the fresh peri-
cardial patch. One patient has already undergone a Ross-Konno
procedure 1 year after the pulmonary autograft patch repair. At the
beginning of the experience 2 patients had xenopericardial patch
closure of the pulmonary defect, and 1 required a reoperation
because of the shrinkage of this patch, but pulmonary valve func-
tion was not deteriorated. The second also had a gradient, which is
now more than 40 mm Hg.
In this series we had only 1 patient who had a Ross-Konno pro-
cedure associated with arch repair and VSD closure. As far as I
know this is the only patient who underwent a primary neonatal
Ross-Konno procedure for IAA associated with severe subaortic
stenosis. Our present policy is to perform the conventional biven-
tricular repair even in presence of a severe narrowing of the
subaortic region. This is rarely associated with subaortic myec-
tomy because of the anatomy and the surgeon’s preference. With
increasing experience, the neonatal Ross procedure will probably
have larger application in this field.
Dr Christo I. Tchervenkov (Montreal, Quebec, Canada). I
rise in defense of the single-stage approach for cardiac defects
with aortic arch obstruction and in defense of the pulmonary
homograft patch aortoplasty. I would also like to recognize the
contributions of your group at Marie Lannelongue Hospital in the
surgical treatment of this challenging group of patients. I am glad
to see that the debate in the last 10 years has shifted away from
whether to adopt a single-stage approach and toward which is the
optimal surgical technique for the aortic arch repair and whether to
use circulatory arrest.
Three years ago at the annual meeting of the Association for
Thoracic Surgery we presented our experience at Montreal
Children’s Hospital with a single-stage approach of intracardiac and
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concomitant aortic arch repair with pulmonary homograft patch aor-
toplasty in 40 patients with a 5% early mortality. Most patients in
our series had transposition complexes and hypoplastic left heart
complex with arch obstruction. Currently for more than 50 patients
the mortality is under 4% and the freedom from reintervention for
recoarctation is approximately 95%, despite the fact that our surgi-
cal technique rarely includes excision of the coarctation shelf.
I believe that your group II, composed of only 8 patients and
with two different patch materials used, is just too small for any
meaningful comparison with the other groups. Furthermore, your
unfavorable experience with only 4 patients with pulmonary
homograft patch aortoplasty is clearly insufficient to discard that
technique as part of the surgical armamentarium, considering the
low recoarctation rate of 8.3% reported by our group.
Have you used pulmonary autograft patch aortoplasty in
patients with transposition complexes, where using the extended
end-to-end anastomosis introduces 2 circumferential suture lines,
with potential for excessive tension at 2 anastomoses? If not, why
not? In our experience we have had no deaths among 22 patients
with transposition complexes and aortic arch obstruction undergo-
ing a single stage-arterial switch operation and aortic arch repair.
Dr Belli. I want to make one point clear concerning the single-
stage versus staged discussion. It is obvious that most of the
patient population of the study fall outside this discussion. There
were 24 patients with IAA type B and 3 with type C. There were
24 patients with coarctation, which was associated, at least in 18
cases, with severe hypoplasia of the entire arch. The presence of
preoperative subaortic stenosis was documented in 18 cases. If we
were to analyze the patients singly, we could certainly find some
candidates adapted to staged management. Essentially, however,
the discussion of single-stage versus staged is excluded for this
particular patient population.
Concerning the homograft patch enlargement, I agree that we
have only a small group of patients, which does not allow us to
make a valuable conclusion. There were 8 patients who had bio-
logic patches: 4 xenopericardial and 4 homograft patches. From
both small groups, 3 had recoarctation. I believe that the outcome
of aortic arch repair with homograft patches is not free from
recoarctation, although it is not so dramatically poor. We perform
this technique preferentially in cases of transposition of the great
arteries, truncus arteriosus associated with IAA, and some other
conotruncal anomalies. Unfortunately, the rate of recoarctation has
not been as good as that reported in your series; it is around 15%
to 20%. However, one should not forget that the population stud-
ied here consisted exclusively of neonates. Independent of the
technique used, we did not observe recurrence in infants beyond
the neonatal period.
With respect to the homograft patch enlargement in the trans-
position setting, as François Lacour-Gayet has reported at the
American Heart Association meeting, in our current practice we
almost always use homograft patch enlargement to adjust the two
new aortic ends. We have not developed our new technique to
obtain a pulmonary autograft patch, which in this condition must
be relatively large.
Dr Thomas L. Spray (Philadelphia, Pa). This is an interesting
technique. What do you think the mechanism is that makes this
fundamentally better than using another patch? Why not use native
pericardium if you think that viability is an issue? When you do
this, you end up putting native pericardium in the pulmonary
artery, which you then may have to use for a Ross-Konno opera-
tion in the future, so now part of the aorta is native pericardium
anyway. Why not use unfixed native pericardium and have viabil-
ity and potentially fewer problems with stenosis?
Dr Belli. I appreciate your question, but I am afraid that I do
not have any data to answer it.
Dr Spray. Do you think that is fundamentally better because it
is living tissue?
Dr Belli. Fundamentally, first we have the surgical comfort of
the biologic patch material to implant. Second, it is living arterial
wall tissue with the potential for growth. However, the main rea-
son was the stability of the initial result at follow-up, with absence
of the risk of patch shrinkage and a risk of the other major com-
plication, which is late aneurysm formation, that must be trivial if
not zero.
